EUGEN is delighted to announce the completion of its merger with RARAS CRO

“What started as almost a utopia back in 2018 to create a company to
support and promote clinical research in Latin America based out of Uruguay,
has now turned into a multinational reality”

Says Claudia Rodriguez, Director of Operations of Eugen and now in her new role at RARAS CRO.

Our merger with the largest Brazilian medical devices CRO and rebranding to RARAS aims at better serving our customers providing now joint local expertise in drug and medical devices development. Expanded geographic presence in Brazil, Panama, Uruguay and our upcoming office in Peru, a stellar team of professionals and state-of-the art technology are differentials that mid-to-low size CROs in the Region lacked and provides expanded access to these tools to a broader audience of clients and patients. While the companies are still transitioning to the new online image and social networks, we invite you to start following us.

For further information please contact: bd@rarascro.com